419 related articles for article (PubMed ID: 14752836)
1. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
[TBL] [Abstract][Full Text] [Related]
2. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
3. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
[TBL] [Abstract][Full Text] [Related]
4. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance-associated hepatic iron overload.
Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y
Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879
[TBL] [Abstract][Full Text] [Related]
6. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
[TBL] [Abstract][Full Text] [Related]
7. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
[TBL] [Abstract][Full Text] [Related]
8. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Loria P; Lonardo A; Carulli N
Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
[No Abstract] [Full Text] [Related]
9. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.
Valenti L; Dongiovanni P; Fracanzani AL; Santorelli G; Fatta E; Bertelli C; Taioli E; Fiorelli G; Fargion S
Dig Liver Dis; 2003 Mar; 35(3):172-8. PubMed ID: 12779071
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.
Raszeja-Wyszomirska J; Kurzawski G; Lawniczak M; Miezynska-Kurtycz J; Lubinski J
World J Gastroenterol; 2010 May; 16(20):2531-6. PubMed ID: 20503453
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
12. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.
Lin TJ; Lin CL; Wang CS; Liu SO; Liao LY
World J Gastroenterol; 2005 Jul; 11(25):3905-8. PubMed ID: 15991291
[TBL] [Abstract][Full Text] [Related]
14. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
[TBL] [Abstract][Full Text] [Related]
15. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
Nelson JE; Brunt EM; Kowdley KV;
Hepatology; 2012 Nov; 56(5):1730-40. PubMed ID: 22611049
[TBL] [Abstract][Full Text] [Related]
16. Steatosis is a cofactor in liver injury in hemochromatosis.
Powell EE; Ali A; Clouston AD; Dixon JL; Lincoln DJ; Purdie DM; Fletcher LM; Powell LW; Jonsson JR
Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.
Zamin I; Mattos AA; Mattos AZ; Migon E; Bica C; Alexandre CO
Arq Gastroenterol; 2006; 43(3):224-8. PubMed ID: 17160239
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
19. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
20. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
